Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · DuoResp Spiromax

DuoResp Spiromax 320 micrograms/9 micrograms inhalation powder · Abschnitt 4.8 · PDF-Seite 26

HOS-215236 · Präparat HOS-155404

System Organ Class Frequency Adverse reaction Infections and infestations Common Candida infections in the oropharynx, pneumonia (in COPD patients) Immune system disorders Rare Immediate and delayed hypersensitivity reactions, e.g. exanthema, urticaria, pruritus, dermatitis, angioedema and anaphylactic reaction Endocrine disorders Very rare Cushing´s syndrome, adrenal suppression, growth retardation, decrease in bone mineral density Metabolism and nutrition Rare Hypokalaemia disorders Very rare Hyperglycaemia Psychiatric disorders Uncommon Aggression, psychomotor hyperactivity, anxiety, sleep disorders Very rare Depression, behavioural changes (predominantly in children) Nervous system disorders Common Headache, tremor Uncommon Dizziness Very rare Taste disturbances Eye disorders Very rare Cataract and glaucoma Uncommon Vision, blurred (see also section 4.4) Cardiac disorders Common Palpitations Uncommon Tachycardia Rare Cardiac arrhythmias, e.g. atrial fibrillation, supraventricular tachycardia, extrasystoles Very rare Angina pectoris. Prolongation of QTc-interval Vascular disorders Very rare Variations in blood pressure Respiratory, thoracic and Common Mild irritation in the throat, coughing, Dysphonia mediastinal disorders including hoarseness Rare Bronchospasm Very rare Paradoxical bronchospasm Gastrointestinal disorders Uncommon Nausea Skin and subcutaneous Uncommon Bruises tissue disorders Musculoskeletal and Uncommon Muscle cramps connective tissue disorders

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.